Pharmacological prophylaxis of venous thromboembolism in adult medical and surgical wards in the Gaza Strip: a multi-centre clinical audit

Abstract

Background Hospital-acquired venous thromboembolism (VTE) has a reported worldwide prevalence of 0•8-11%. It is the most common cause of preventable death, underlining the importance of VTE prevention. Methods This clinical audit was conducted in adult medical and surgical wards of three hospitals in Gaza, from March to August, 2017. Patients were assessed prospectively using the modified Padua Prediction Score risk assessment model and the Caprini Score to categorise patients as having high or low risk of developing VTE.

Risk Assessment and Prophylaxis of Venous Thromboembolism in Patients of Medical Ward of Northwest General Hospital and Research Center, Peshawar, Pakistan: A Quality Improvement Project

“…Similarly, among the patients eligible for VTE prophylaxis only 22.2% received it. These findings are consistent with a multicentre study conducted in Gaza which also depicted poor compliance regarding VTE prophylaxis [ 8 ]. In comparison with underdeveloped countries, the implementation of VTE prophylaxis is higher in developed countries [ 12 ].…”

“…VTE is not only a frequent cause of adverse prognosis in hospitalized patients but also contributes to more than 10% of hospital-related deaths [ 2 , 11 ]. Hospital-acquired VTE has a prevalence of 0.8-11% worldwide [ 8 ]. Well-researched and widely accepted guidelines are available for risk assessment and prophylaxis of VTE in hospitalized patients [ 2 ].…”

“…Researches have shown that despite the availability of adequate guidelines, the risk assessment and prophylaxis of VTE are under-practiced in developing countries [ 8 ]. Consequently, besides being adversely linked to patients’ health this negligence also imposes a significant financial burden on already struggling economies [ 3 ].…”